U.S. Employers Changed The Health Plan Cost Increase Curve, Researchers Say

U.S. employers, their benefits advisors, and health care products and services suppliers did a great job of holding down increases in health care costs between 2010 and 2024.

Back in 2010, actuaries at the Centers for Medicare & Medicaid Services predicted that employers would provide health coverage for just 168 million people in 2024, at an average cost of $9,556 per plan participant, according to a new research paper draft written by David Cutler and Lev Klarnet.

Instead, employer-sponsored plans ended up covering 179 million people, at an average cost of $8,002 per participant.

The number of people covered was 5% higher than the CMS economists had predicted, and the per-participant cost was 16% lower than predicted.

Employer health plans ended up spending a total of $1.4 trillion, or 11% less than what the CMS actuaries predicted for 2024 in 2010.

Total U.S. health care spending amounted to $5.3 trillion, or 16% less than the CMS actuaries’ forecast.

“The slowdown in medical spending growth is not only large substantively, it is unprecedented historically.” Cutler and Klarnet write in the paper.

Cutler is an economist and dean of social science at Harvard, and Klarnet is a graduate student at Harvard.

The researchers presented the paper draft last week at a conference organized by the Brookings Institution.

What it means: Employers and benefits advisors may sometimes feel as if they have no ability to fight health benefits cost increases.

But the Cutler-Klarnet paper shows that they did succeed at “flattening” the U.S. health benefits cost increase curve that showed up in actuaries’ and economists’ data in 2010.

Because costs grew more slowly than the CMS actuaries had expected, the United States spent $977 billion less on health care in 2024 than predicted, and employers spent $267 billion less.

The slowdown in cost increases saved employers an average of $1,555 per plan participant in 2024.

An obstacle: The slowdown in U.S. health care cost increases was obvious from 2010 to 2021.

In 2021, the cost of COVID-19 vaccines and treatments pushed health care spending over about $500 billion, Cutler and Klarnet report.

But spending then fell to close to what it was before the pandemic started.

Sources of savings: Cutler and Klarnet estimate that share of the overall U.S. health care spending slowdown produced was:

  • 7% for the decrease in the percentage of people who smoke and other improvements in population health.
  • 11% to 27% for insurers’, self-insured employer plans’ and other payers’ efforts to hold down costs.
  • 21% for advances in technology — including advances in technology that reduced the need for inpatient hospital care.
  • 24% for slower price growth for medical products and medical services.

The future: U.S. health care payers and providers need to continue to look for ways to reduce costs, the researchers write.

“While the health care cost curve has been bent, it likely has not been bent enough,” the researchers say. “Medical spending is still higher in the U.S. than elsewhere, and health outcomes do not appear to justify that additional expense.”

But, thanks to the work U.S. payers, providers and suppliers have already done, “technology is no longer as vital a driver of increased spending,” the researchers write. “In addition, payers are better at fostering demand and supply conditions that lead to lower spending growth.”

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square